Literature DB >> 23298204

The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules.

Erin J Adams1, Adrienne M Luoma.   

Abstract

The MHC fold is found in proteins that have a range of functions in the maintenance of an organism's health, from immune regulation to fat metabolism. Well adapted for antigen presentation, as seen for peptides in the classical MHC molecules and for lipids in CD1 molecules, the MHC fold has also been modified to perform Fc-receptor activity (e.g., FcRn) and for roles in host homeostasis (e.g., with HFE and ZAG). The more divergent MHC-like molecules, such as some of those that interact with the NKG2D receptor, represent the minimal MHC fold, doing away with the α3 domain and β2m while maintaining the α1/α2 platform domain for receptor engagement. Viruses have also co-opted the MHC fold for immune-evasive functions. The variations on the theme of a β-sheet topped by two semiparallel α-helices are discussed in this review, highlighting the fantastic adaptability of this fold for good and for bad.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298204     DOI: 10.1146/annurev-immunol-032712-095912

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  75 in total

1.  The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.

Authors:  Yi Tian Ting; Jan Petersen; Sri H Ramarathinam; Stephen W Scally; Khai L Loh; Ranjeny Thomas; Anish Suri; Daniel G Baker; Anthony W Purcell; Hugh H Reid; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

2.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 3.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

Review 4.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

5.  Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.

Authors:  Milan S Geybels; Shanshan Zhao; Chao-Jen Wong; Marina Bibikova; Brandy Klotzle; Michael Wu; Elaine A Ostrander; Jian-Bing Fan; Ziding Feng; Janet L Stanford
Journal:  Prostate       Date:  2015-09-18       Impact factor: 4.104

Review 6.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

7.  Unusual evolutionary conservation and further species-specific adaptations of a large family of nonclassical MHC class Ib genes across different degrees of genome ploidy in the amphibian subfamily Xenopodinae.

Authors:  Eva-Stina Edholm; Ana Goyos; Joseph Taran; Francisco De Jesús Andino; Yuko Ohta; Jacques Robert
Journal:  Immunogenetics       Date:  2014-04-27       Impact factor: 2.846

Review 8.  Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them.

Authors:  Erin J Adams
Journal:  Curr Opin Immunol       Date:  2013-10-11       Impact factor: 7.486

Review 9.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

Review 10.  Coevolution of T-cell receptors with MHC and non-MHC ligands.

Authors:  Caitlin D Castro; Adrienne M Luoma; Erin J Adams
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.